Using biomarkers to adjust corticosteroid dose in patients with severe asthma

Use of biomarkers may help reduce inhaled corticosteroid burden in severe asthma if treatment advice is followed. T2 low asthma is less common than previously thought. https://bit.ly/3rG7SZ2

Detalles Bibliográficos
Autor principal: Jones, Thomas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291938/
https://www.ncbi.nlm.nih.gov/pubmed/34295402
http://dx.doi.org/10.1183/20734735.0324-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291938/
https://www.ncbi.nlm.nih.gov/pubmed/34295402
http://dx.doi.org/10.1183/20734735.0324-2020

Ejemplares similares